Cargando...
Insulin Degrading Enzyme inhibition, a novel therapy for type 2 diabetes?
The Insulin Degrading Enzyme (IDE) has been identified as a type 2 diabetes and Alzheimer’s disease susceptibility gene though its physiological function remains unclear. Maianti et al. (2014) now propose that an IDE inhibitor may be a promising therapeutic strategy for type 2 diabetes.
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4144405/ https://ncbi.nlm.nih.gov/pubmed/25100059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2014.07.016 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|